Search

Schrodinger Inc

Ouvert

SecteurSoins de santé

17.8 9.27

Résumé

Variation du prix de l'action

24h

Actuel

Min

15.44

Max

16.32

Chiffres clés

By Trading Economics

Revenu

-196M

-60M

Ventes

-29M

59M

BPA

-0.62

Marge bénéficiaire

-102.456

Employés

850

EBITDA

-94M

-58M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+33.05% upside

Dividendes

By Acuity

Prochains Résultats

5 août 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

178M

1.1B

Ouverture précédente

8.53

Clôture précédente

17.8

Sentiment de l'Actualité

By Acuity

50%

50%

175 / 340 Classement par Healthcare

Schrodinger Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

3 août 2026, 19:51 UTC

Correlated Moves

Schrodinger Inc shares are higher, reflecting broader market gains amid a drop in oil prices and positive sentiment in the technology sector.

31 juil. 2026, 19:46 UTC

Correlated Moves

Schrodinger Inc shares are lower amid declining first-quarter results and broader market pressure, despite an earlier rebound from session lows.

30 juil. 2026, 18:46 UTC

Correlated Moves

Schrodinger Inc. advanced during Thursday's session, supported by broader market gains despite earlier pulling back from a session high.

29 juil. 2026, 20:51 UTC

Correlated Moves

Schrodinger Inc shares are lower in after-market trading, influenced by a broader market downturn and rising crude oil prices amid geopolitical tensions.

28 juil. 2026, 23:01 UTC

Schrodinger Inc. shares declined in after-market trading, remaining below their 20-day moving average amid broader market strength and pressure on technology stocks.

27 juil. 2026, 22:51 UTC

Schrodinger Inc. shares are higher in after-market trading, despite remaining below their 20-day moving average amid broader market dynamics and falling crude oil prices.

24 juil. 2026, 15:11 UTC

Schrodinger Inc shares are declining today, continuing a downward trend since Thursday's close. A pullback in crude oil prices may be affecting investor sentiment.

20 juil. 2026, 15:12 UTC

Correlated Moves

Schrodinger Inc. shares are lower amid a decline in the ARK Genomic Revolution ETF and broader market pressures, despite a slight rebound earlier in the session.

Comparaison

Variation de prix

Schrodinger Inc prévision

Objectif de Prix

By TipRanks

33.05% hausse

Prévisions sur 12 Mois

Moyen 20.33 USD  33.05%

Haut 24 USD

Bas 17 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

5 ratings

4

Achat

1

Maintien

0

Vente

Sentiment

By Acuity

175 / 340Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Schrodinger Inc

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
help-icon Live chat